InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Nucleic Acid Therapeutics Market – (By Technology (RNA targeted therapeutics, Gene Therapies, Epigenetic and microRNA modulating therapies, Genome editing therapies, Others), By Application (Autoimmune Disorders, Genetic Disorders, Infectious Diseases, Cancer, Others), By End User (Hospitals & Clinics, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Nucleic Acid Therapeutics Market is valued at US$ 4.93 billion in 2023, and it is expected to reach US$ 13.86 billion by 2031, with a CAGR of 13.8% during the forecast period of 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2548
Nucleic acid therapeutics refers to a group of medical procedures that make use of therapeutic nucleic acids like DNA and RNA to cure or prevent illness. The market is expected to grow because there has been a surge in research efforts to enhance healthcare systems globally due to the increasing number of chronic diseases and genetic disorders. In addition, increases in demand for pharmaceuticals and healthcare services, along with innovations in biological products and DNA therapies, are driving the nucleic acid therapeutics industry forward.